(Q45870223)

17 December 2017

title

Do we need oncology trials tailored for the elderly or frail? (English)

1 reference

17 December 2017

author name string

Hans-Joachim Schmoll

series ordinal

1

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

17 December 2017

published in

The Lancet

1 reference

17 December 2017

volume

377

1 reference

17 December 2017

issue

9779

1 reference

17 December 2017

page(s)

1725-1727

1 reference

17 December 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960654-5

7 January 2021

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960654-5

7 January 2021

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960654-5

7 January 2021

Colon cancer in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960654-5

7 January 2021

Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960654-5

7 January 2021

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960654-5

7 January 2021

10.1016/S0140-6736(11)60654-5

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017